Brief: Innate Pharma To Present New Lacutamab Data From TELLOMAK Trial

Innate Pharma SA

09/06/2021 11:08

June 9 (Reuters) - INNATE PHARMA SA  IPH.PA :
    * NEW LACUTAMAB DATA FROM TELLOMAK TRIAL TO BE SHOWCASED IN
ORAL
PRESENTATION AT UPCOMING 16TH INTERNATIONAL CONFERENCE ON
MALIGNANT LYMPHOMA
    * FIRST CLINICAL DATA OF MYCOSIS FUNGOIDES PRESENTED FROM
THE
TELLOMAK TRIAL

Source text for Eikon:  ID:nGNX5KtlS7 
Further company coverage:  IPH.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))